Fluorine-19 (19F) MRI (19F-MRI)
is a promising
method for quantifying biomedical research and clinical applications
without background interference. Nevertheless, dependency on high-field
MRI systems limits the applicability of 19F-MRI. Low-field
MRI systems are more common than high-field MRI systems. Hence, developing 19F-MRI at low-field MRI devices can promote the 19F-MRI translation in medical diagnosis. The detection sensitivity
of fluorine agents is critical in 19F-MRI. Reduction of
the 19F spin-lattice relaxation time (T
1) enables an improved detection sensitivity while requiring
ultrashort echo time (UTE) imaging methods to reduce the negative
spin–spin relaxation (T
2) decay
effect. However, conventional UTE sequences require hardware with
high performance. Herein, we introduce the k-space
scaling imaging (KSSI) MRI sequence that accomplishes sampling k-space with variable scales to implement hardware-friendly
UTE 19F-MRI compatible with low-field MRI systems. We implemented
experiments with swine bone, a perfluorooctyl bromide (PFOB) phantom,
and one tumor-bearing mouse on two self-customized low-field MRI systems.
The swine bone imaging validated the ultrashort TE of KSSI. Under
high concentrations of manganese ferrite, a high signal-to-noise ratio
was shown in the imaging of a fluorine atom concentration of 658 mM,
which indicated high-sensitivity detection of KSSI. Moreover, the
KSSI sequence exhibited a 7.1 times signal-to-noise ratio of spin
echo sequence on the PFOB phantom imaging with a fluorine atom concentration
of 3.29 M. Additionally, the various concentrations of the PFOB phantom
imaging revealed quantifiable capacity. Finally, the 1H/19F imaging was implemented with KSSI on one tumor-bearing
mouse. This method provides the potential for clinical translation
of fluorine probes at low-field MRI systems.